1Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom

2EbMCsquared, a Community Interest Company Bath, United Kingdom

The authors have no conflicts of interest to declare.

All authors were members of the British Ivermectin Recommendation Development (BiRD) panel at the “Evidence to Decision” event convened on February 20, 2021. Mr Bryant and Dr Lawrie were members of the steering group and did not vote. Drs Fordham and Mitchell were ordinary members of the panel. BiRD continues as a public information activity managed by EbMCsquared, a nonprofit Community Interest Company. Dr Fordham is a member of the Health Advisory and Recovery Team (HART), an unincorporated membership association with no financial or material interests in ivermectin or any other medical product. This work is not a project of HART and is not funded in any way by them.